GENE ONLINE|News &
Opinion
Blog

2018-05-02|

May 2, 2013: U.S. Research Team Published the First Genetic Test Predicting Surgery Efficacy

by GeneOnline
Share To

On May 2, 2013, the U.S. research team published a seven-year research report in the American Journal of Human Genetics, announcing the first genetic test to predict benefits of gastric bypass surgery, also known as Roux-en-Y gastric bypass (RYGB). The test results can be used to determine the long-term success rate of RYGB with up to 70% of accuracy. Discovery of the correlation between certain genes and the effect of RYGB stands for a strong evidence of how genetic factors influence patients’ response to surgery, and also represents a breakthrough in genetic technology on improving clinical medicne.

Reference
https://www.cell.com/ajhg/issue?pii=S0002-9297(13)X0006-0

Image Source
https://commons.wikimedia.org/wiki/File:Blausen_0776_Roux-En-Y_01.png

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
Delivering Affordable Biologic Medicines Worldwide: An Interview with Tanvex Chairman and CEO, Henry Chen
2024-07-11
GeneOnline’s Weekly News Highlights: Aug 21-25
2023-08-28
BIO 2022: Addressing Bottlenecks in Gene Therapy
2022-08-03
LATEST
Bayer’s NUBEQA: Breakthrough in Prostate Cancer with 46% Risk Reduction and Future FDA Expansion Plans
2024-09-19
Highlights from ESMO 2024: Key Oncology Advances from Major Pharmaceutical Companies
2024-09-19
Five Biotech Stocks Soar: Eyes on Halozyme, United Therapeutics, Harmony, Ligand, and ADMA
2024-09-19
Biotech Industry Trends in 2024: A Look at the Billions in Oncology Deals
2024-09-18
Thailand’s Biotech Boom: Innovations in Precision Medicine, Cell Therapy, and Wellness Drive APAC Leadership
2024-09-18
International Green Party Showcases AI Solutions for a Healthy and Sustainable Future
2024-09-16
Bio Asia Pacific 2024 Close ASEAN Collaborations: Catalyzing Innovation and Global Partnerships
2024-09-12
EVENT
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
Scroll to Top